These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2902727)

  • 1. Pharmacological profile of neuromuscular blocking agents: present and future trends.
    Agoston S
    Acta Anaesthesiol Belg; 1988; 39(3 Suppl 2):235-7. PubMed ID: 2902727
    [No Abstract]   [Full Text] [Related]  

  • 2. Vecuronium--another intermediate duration neuromuscular blocking drug.
    Drug Ther Bull; 1987 Mar; 25(5):19-20. PubMed ID: 2434293
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers.
    Caldwell JE; Szenohradszky J; Segredo V; Wright PM; McLoughlin C; Sharma ML; Gruenke LD; Fisher DM; Miller RD
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1216-22. PubMed ID: 7932174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular block by vecuronium: simulation with a flow-volume model.
    Nigrovic V
    Eur J Anaesthesiol; 1994 Mar; 11(2):65-74. PubMed ID: 7909750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatobiliary disposition of vecuronium bromide in man.
    Bencini AF; Scaf AH; Sohn YJ; Kersten-Kleef UW; Agoston S
    Br J Anaesth; 1986 Sep; 58(9):988-95. PubMed ID: 2875725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of nicorandil on the neuromuscular block induced by vecuronium].
    Oyanagi S; Matsuda T; Abe H; Mori H
    Masui; 1995 Jul; 44(7):986-9. PubMed ID: 7637190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable designs of clinical trials of neuromuscular blocking agents: an example of studies comparing rocuronium and vecuronium.
    Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Antonio-Ocampo A; Salmerón J
    Med Sci Monit; 2005 Feb; 11(2):PI22-30. PubMed ID: 15668623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and pharmacodynamics of vecuronium in children].
    Steinbereithner K; Fitzal S; Schwarz S; Gilly H; Semsroth M; Weindlmayr-Goettel M
    Cah Anesthesiol; 1984; 32(1):5-10. PubMed ID: 6152193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.
    Cembala TM; Forde SC; Appadu BL; Lambert DG
    Eur J Pharmacol; 2007 Aug; 569(1-2):37-40. PubMed ID: 17588565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants.
    Hilgenberg JC
    Anesth Analg; 1983 May; 62(5):524-31. PubMed ID: 6132564
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuromuscular and circulatory effect of NC45 in rats].
    Amaki Y; Wada T; Koyama T; Tanak K; Kobayashi K
    Masui; 1983 Jun; 32(6):737-41. PubMed ID: 6137575
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New muscle relaxants.
    Fahey MR; Miller RD
    Contemp Anesth Pract; 1983; 7():61-81. PubMed ID: 6136393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The interaction between vecuronium (NC 45) and pancuronium or d-tubocurarine in the rat phrenic nerve-hemidiaphragm preparation].
    Amaki Y; Koyama T; Tanaka K; Kobayashi K
    Masui; 1984 Oct; 33(10):1137-40. PubMed ID: 6151603
    [No Abstract]   [Full Text] [Related]  

  • 16. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of atracurium, vecuronium (Org NC 45) and pancuronium.
    Gramstad L; Lilleaasen P; Minsaas B
    Br J Anaesth; 1983; 55 Suppl 1():95S-96S. PubMed ID: 6134541
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of atracurium and vecuronium given in continuous injection].
    Neidhardt A; Neidhardt-Audion M; Bachour K
    Cah Anesthesiol; 1984 Dec; 32(8):645-8. PubMed ID: 6152194
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of intermediate acting muscle relaxants by infusion: the future.
    Mirakhur RK; McCourt KC; Kumar N
    Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of the muscle relaxant drug Org NC-45 and each of its hydroxy metabolites in dogs.
    Booij LH; Vree TB; Hurkmans F; Reekers-Ketting JJ; Crul JF
    Anaesthesist; 1981 Jul; 30(7):329-33. PubMed ID: 6115592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.